Nocturia, nocturnal polyuria, and nocturnal enuresis in adults: What we know and what we do not know

被引:0
|
作者
Chang, Tien-Lin
Kuo, Hann-Chorng [1 ]
机构
[1] Hualien Tzu Chi Hosp, Dept Urol, Buddhist Tzu Chi Med Fdn, 707,Sect 3,Chung Yang Rd, Hualien, Taiwan
来源
TZU CHI MEDICAL JOURNAL | 2024年 / 36卷 / 04期
关键词
Bladder outlet obstruction; Lower urinary tract dysfunction; Nocturnal incontinence; Urinary frequency; URINARY-TRACT SYMPTOMS; TIBIAL NERVE-STIMULATION; EUROPEAN ASSOCIATION; UROLOGY GUIDELINES; CIRCADIAN-RHYTHM; SLEEP QUALITY; BLADDER; PATHOPHYSIOLOGY; DESMOPRESSIN; WOMEN;
D O I
10.4103/tcmj.tcmj_53_24
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nocturia is defined as the nocturnal frequency of one or more voiding episodes per night. It increases with aging and has an impact on sleep quality and the risks of falling and mortality. Nocturia disorder involves nighttime frequency, nocturnal polyuria, and nocturnal enuresis. In older adults with nocturia disorder, multiple factors could contribute to nocturia severity and characteristics, including poor sleep quality, lower urinary tract dysfunction, and excessive fluid output. Several nonurological medical diseases have been found to result in nocturia, such as hypertension, congestive heart failure, chronic kidney disease, chronic obstructive pulmonary disease, metabolic syndrome, and diabetes. Urological and medical assessments should be performed to diagnose nocturia disorder. A frequency volume chart to evaluate the nocturnal polyuria index, functional bladder capacity, and urodynamic study can reveal the presence of nocturnal polyuria and lower urinary tract dysfunction. Treatment should be based on multiple nocturia etiologies, and a combination of multiple therapies for individual pathophysiology will achieve a better treatment outcome.
引用
收藏
页码:370 / 376
页数:7
相关论文
共 50 条
  • [41] Neurogenic Inflammation in the Context of Endometriosis-What Do We Know?
    Velho, Renata Voltolini
    Taube, Eliane
    Sehouli, Jalid
    Mechsner, Sylvia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (23)
  • [42] Drug Transfer to the Fetus and to the Breastfeeding Infant: What Do We Know?
    Bernick, Steven J.
    Kane, Sunanda
    CURRENT DRUG DELIVERY, 2012, 9 (04) : 350 - 355
  • [43] Understanding the role of chronopharmacology for drug optimization: what do we know?
    Fujimura, Akio
    Ushijima, Kentaro
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2023, 16 (07) : 655 - 668
  • [44] Reproductive coercion and abuse in Australia: what do we need to know?
    Carter, Allison
    Bateson, Deborah
    Vaughan, Cathy
    SEXUAL HEALTH, 2021, 18 (05) : 436 - 440
  • [45] Androgen therapy in women: What we think we know
    Drillich, Ann
    Davis, Susan R.
    EXPERIMENTAL GERONTOLOGY, 2007, 42 (06) : 457 - 462
  • [46] What do we know about phytotherapy of benign prostatic hyperplasia?
    Allkanjari, Olta
    Vitalone, Annabella
    LIFE SCIENCES, 2015, 126 : 42 - 56
  • [47] Infertility and Preterm Delivery: What Do We Know and Where Do We Go from Here?
    Wise, Lauren A.
    PAEDIATRIC AND PERINATAL EPIDEMIOLOGY, 2015, 29 (02) : 97 - 100
  • [48] Coronary heart disease in women: what do we know now?
    Duvernoy, Claire S.
    FUTURE CARDIOLOGY, 2005, 1 (05) : 617 - 628
  • [49] Perioperative Red Blood Cell Transfusion: What We Do Not Know
    Lei, Chong
    Xiong, Li-Ze
    CHINESE MEDICAL JOURNAL, 2015, 128 (17) : 2383 - 2386
  • [50] What we do not know about pregnancy in hereditary neuromuscular disorders
    Argov, Zohar
    de Visser, Marianne
    NEUROMUSCULAR DISORDERS, 2009, 19 (10) : 675 - 679